Winow Automation is reimagining the modern workshop, utilizing robotics, machine vision and AI to free humans from repetitive and tedious tasks and foster an agile production. Our mission at Winow Automation is to revolutionize tool management strategies in metal cutting companies with the aid of Industry 4.0 technologies.

Anteroz is the story of friends who found a flavour and a secret known by few but worth sharing with the whole world: Mamajuana, a botanical rum-based drink aged on a 500-year-old Dominican tradition hailed as a source of vitality, the cure to whatever tortures and an aphrodisiac. The stories behind Mamajuana and the joy and passion with which the Dominicans serve and enjoy this exotic drink personify the way they take life itself: as if it is not lived to its fullest unless you do what turns you on. To share this message with the world, we set out to create a global brand and spread this message in a bottle. As a company, we believe in bringing something unique to the world in a sustainable way, never forgetting our roots: just the way we learned in the land of the Midnight Sun and the Northern Lights. It is also fundamental to Anteroz to never forget our products’ roots. Crafted in the Dominican Republic, Anteroz is named after Anteros, the Greek God of love and son of Aphrodite, following the legendary Mamajuana property of manifesting amorous desires. We are determined to honour the Mamajuana tradition with an evolutionary drinking experience and are on a mission to live up to the reputation and be a real turn-on for both those who sip and those who pour our unique blend of fiery herbs and luscious honey-infused spirits.

Cavai AS was founded in December 2017 with the goal of revolutionizing online advertising. User experiences have largely been neglected on the web, and Cavai saw early on that chatbot technology, which has initially been used in customer service, could be a wonderfully good advertising product. Usually, chatbot technology is used as customer service on its own website, while Cavai's platform is built to be able to use chatbot technology on millions of websites for contextual advertising. The team today consists of 15 people, and the product has been launched in Norway, Finland, Sweden and the UK with 50 paying customers. Customers are very pleased and report that Cavai's technology is having a very good effect on completed advertising campaigns. Cavai will have its first month of positive operating results in October and looks to have sales of around 3 million in 2019. Next year will be a big growth year, where we have budgeted with a turnover of NOK 41 million. This growth has also been discussed by Finansavisen, where as part of Finansavisen's web-TV series "Vext", Cavai filmed his meeting with advertising legend Sir Marting Sorell in London. For more information, see https://finansavisen.no/vext/tech/2019/10/23/7465643/chatbot-company-cavai-2020-blir-the-store-growst>  To finance further growth, we are now running a seed funding round of NOK 9.5 - 15 million. The company is priced at NOK 60 million pre-money. For more information see the investor summary, investor presentation and subscription form attached.

Klarna offer smoooth payments to 130.000 webshops and retailers across the globe. The company has 2500 employees spread over our 14 markets. Klarna Checkout is the main product, which offers merchants 1 integration, 1 agreement, 1 settlement for handling payments online and in stores. Klarna Norway AS has 15 (and increasing) employees who work at the 26th floor at Posthuset in Oslo.

Biim is a global medical company developing low-cost portable and pocketable ultrasound devices that connect to IOS and Android interfaces. Biim is entering the commercial stage with both FDA and CE approvals in place. The company has signed a 3-year distr. agreement with AngioDynamics worth a minimum of 20 million USD. Year-to-date revenue has exceeded more than 2.4 million USD. The company has secured a credit facility of 4 million USD with DNB. Biim is raising up to 9 million USD for the development of two new probes and to expand the global footprint to more than 30 countries.

Versiro develops software that accelerates the energy transition. Renewable electricity is great for the environment but difficult to plan because its production depends on uncertain weather conditions. Versiro develops an AI copilot that helps renewable producers make smart decisions in real time while considering these uncertainties. This assists the integration of renewable energy and increases its profitability, two key factors to enable the green energy transition. Versiro was founded by researchers at the Norwegian University of Science and Technology (NTNU) and follows the observation that, in electric power systems, the traditional pipelines from research to industry are too outdated to keep up with the fast-paced world of machine learning.

Bile duct cancer is an aggressive form of cancer with an extremely poor overall five-year survival rate of just 2-5 %. Classified as an orphan disease, annual incidence in Europe and the United States of 15-22,000 patients, and a significantly higher incidence in Asia, makes it a major player and the deadliest of the gastrointestinal cancers. Only a small number of patients are eligible for a complete surgical resection by local resection or liver transplantation, and more than 50% of these relapse. The vast majority are treated by gemcitabine-based palliative chemotherapy with a life expectancy of 11 months, and five-year survival rate of zero %. Thus, there is an urgent and unmet medical need to develop new and better treatment strategies for these patients. The innovations developed by Seald are a result of adopting a multidisciplinary approach to the diagnosis and treatment of bile duct cancer, based on extensive drug sensitivity assays on living cancer cells, molecular biomarkers, DNA sequencing, extensive bioinformatics analyses and zebrafish models. Sealds’s holistic approach is unique with possible modes of action that can be used on other solid cancers. Our technology includes drug repurposing and innovation on new medical substances, diagnostics and methodology. The stipulated pharma market globally is USD 2.1-4.2 billion, in addition to the markets for diagnostics and platform technology

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Nordic Data Resources is a leading online data provider, well established in all the Nordic markets after a successful market launch in Q4 2015. We have run more than 1000 campaigns with 100 media agencies in our first 18 months, which generated revenue of € 0,5 million in 2016. We have a monthly run rate of more than € 100 k, which will increase significantly moving forward, particularly when we have globally launched our data. 1) PRODUCT We have developed a scalable, full-reach consumer classification online audience data suite, available for any programmatic platform and digital channel. We specialize in geo-targeting and consumer classification data to reach the entire population. Our data provide a unique way of targeting audiences in a safe and reliable way, available for both buy-side and sell-side, as well as data exchanges and DMPs. Please look at our video presenting the consumer classification audience data; https://vimeo.com/193398498. 2) REVENUE MODEL We distribute our data through programmatic trading platforms and data exchanges to advertisers/agencies (buy-side) and publishers (sell-side). Our revenue is driven by ad impressions using our data to target more effectively. We offer CPM based pricing model in the programmatic platforms, as well as a monthly fixed DMP agreement (recurring revenue model) 3) STRONG MARKET GROWTH / CUSTOMERS The data market is driven by the strong growth in the programmatic buying of ads on the internet, mobile, and soon TV. It’s the best-performing sector in the ad industry (40% growth in 2016). Our market is both the media buyer and the publishers; Agency customers / buy-side We have run more than 1000 campaigns with 100 agencies and all of the global media agency groups in the Nordic countries. See more about our Buy Side offering; http://nordicdataresources.com/agencies/ Publisher customers / sell side We launched our audiences in the Publisher market in Q1 and are now starting up with leading Nordic publishers, both broadcasters and online publishers. See more; http://nordicdataresources.com/publishers/ 4) GLOBAL PARTNERSHIPS We work closely with global players in the online data /programmatic advertising industry, who have established platforms, infrastructure, and customer bases, which helps us to scale our business. We have focused on this since we started and have many great partners like Oracle, MediaMath, Google, Experian, Adform, Semasio, InsightOne, Digital Element, and son. You can see more on http://nordicdataresources.com/platforms/ 5) SCALABLE BUSINESS MODEL Data is the new gold on the internet and represents a strong growth area, growing together with programmatic trading's 30-40% market share. It is predicted that programmatic buying and selling will soon and completely take over the ad market. We have built a global distribution from day one with the leading data exchanges and programmatic trading platforms, so we have a very scalable business and revenue model. We have successfully launched our data in the Nordic markets and are now launched in Germany. Nordic Data Resources has an international "Go to Market" strategy where we plan to globally launch our data in the next 3-9 months. We are able to do this since we have a global audience data set and distribution partners, the key job is to make trading desks and media agencies aware of the existence and great value. As soon as they have tested the data, they can measure their performance, which drives the use of more data. 6) EXPERIENCED  FOUNDER/MANAGEMENT TEAM We are a founding team of 19 internet veterans, and all of us have long internet and online advertising experience. See http://nordicdataresources.com/about/ for the team overview. All in all, the founding team has a total of 150 years of Internet/advertising/data background;

Bookd AS ble etablert i 2021 og jobber med å forenkle bookingprosesser i underholdningsbransjen. Vårt fokus er å tilby underholdning på en enkel og intuitiv måte til bedrifts- og privatarrangementer. Vi har utviklet en app (iOS) hvor man kan finne og booke underholdning på en enkel måte. Vi tilbyr artister, DJs, komikere, foredragsholdere, dansere, kokker og annen underholdning som passer til ulike typer arrangementer. I 2022 er målet å etablere seg i Norge før vi skal skalere videre til nye markeder.Vi har en stor profilbase, samt gode og etablerte partnerskap med flere av Norges største eventbyråer og bedrifter.

Live healthier, easy: Our digitalized nutritionist shows the way, far away from calorie counting and extreme diets. As a company, we're working towards a healthier society on global scale – and global impact, starts internally; We believe a healthy job experience sets you up to thrive professionally and personally. You find our growing and remote team distributed through Europe, where it’s not about showing up at one office every day, but showing up at your best. Do yourself and the world a favor; look through our website and send us a message to carl@anti.diet, and let's see what we can do together!

Globus.ai is cloud based, human centric software that enables staffing agencies and recruiters to place more candidates – faster. Much faster. From requests to search, matching and booking – the whole process can take seconds. Even with high volume job requirements. Our customers typically improve their results (net fee income) with 40%. Globus.ai has developed a unique and intelligent software that enables staffing agencies and recruiters to find and place people with relevant skills and competencies– perfectly matching the needs of their clients. Thanks to human centric artificial intelligence, even the incoming orders are handled automatically, but still in a personal way. Then - the placing of competencies and interests with matching roles, is done within minutes. Due to machine learning, this intelligent process will speed up over time, and replace hours and minutes with seconds. Globus.ai can both speed up and transform you as a professional - and boost your recruiting business.

We help rental services get ready for the future The development is clear – We need to make better use of our resources. We need a more circular economy where products are reused by more people and have a longer lifetime. In this picture, renting and subscription of products and services plays an important role. Sharefox has developed a technology platform that enables new models for both startups and established businesses. We are a passionate and highly skilled team of about 12 persons in Oslo, and 10 developers working remotely. In March 2022 we secured 23 million NOK in funding, and will use this money to scale the company further, including going internationally. You can currently find us at Vollebekk Fabrikker in Oslo, but will move to an other place in Oslo in the autumn of 2022.

Vilje Bionics is a fast-growing medical exoskeleton startup based in Oslo, Norway. Our mission is to improve the lives of people with arm and hand disabilities by providing them with innovative, high-quality exoskeletons that can enhance their mobility and independence. We are a passionate team that is committed to making a positive impact on people's lives.

We help: 🚀 Entrepreneurs build the foundation for a profitable scalable business and raise money from investors 🦄 We invest in B2B Post Revenue Nordic companies 💌 We continuously share knowledge via our channels and newsletter to empower the startup community. And we do much more. We are always on the move. We are a team of angel investors and startup advisors here to support entrepreneurs, CEOs and leaders reach new heights.